Food and Drug Administration, U.S. Department of Health and Human Services - December 10, 1987
Susan Cruzan - (301) 443-3285
The Food and Drug Administration said today that Armour Pharmaceutical of Blue Bell, Pa., is voluntarily withdrawing 208 lots of H.T. Factorate Antihemophilic Factor (Human) distributed to hemophilia patients and doctors who treat them. The product was made using an old heat treatment. Six patients receiving three lots
Food and Drug Administration, U.S. Department of Health and Human Services - November 25, 1987
Susan Cruzan - (301) 443-3285
The Food and Drug Administration announced today that Bristol-Myers Company of New York, N.Y., will begin tests in human volunteers of a biotech-produced experimental vaccine to prevent infections with the virus that causes AIDS -- Human Immunodeficiency Virus (HIV). This is the second experimental vaccine approved for
Food and Drug Administration, U.S. Department of Health and Human Services - June 19, 1987
Bill Grigg/David Duarte; (301) 443-4177
Increased condom testing by the Food and Drug Administration has led to 19 detentions of foreign-made condoms at U.S. borders and has resulted in recalls by three U.S. manufacturers, FDA Commissioner Frank E. Young, M.D., Ph.D., announced today. To ensure that condoms are meeting required standards, FDA has increased i
Food and Drug Administration, U.S. Department of Health and Human Services - May 21, 1987
Bill Grigg; (301) 443-4177
HHS Secretary Otis R. Bowen, M.D., today announced a revision of the Food and Drug Administration s regulations that will make promising experimental drugs more readily available to desperately ill or dying patients. Under the final procedures announced today, Secretary Bowen said, drugs that are in controlled clinical
Food and Drug Administration, U.S. Department of Health and Human Services - April 20, 1987
Susan Cruzan; (301) 443-3285
The Food and Drug Administration today licensed a commercial test kit -- previously used only in a research setting -- for screening blood and for validating an initial screening of donated blood for antibodies to the virus that causes AIDS, acquired immunodeficiency syndrome. FDA Commissioner Frank E. Young, M.D., Ph.
Food and Drug Administration, U.S. Department of Health and Human Services - Friday, March 20, 1987
James Brown; (202) 245-6867
Robert E. Windom, M.D., assistant secretary for health, today announced that the Food and Drug Administration has approved the drug zidovudine, commonly known as azidothymidine, or AZT , to help certain patients with Acquired Immunodeficiency Syndrome (AIDS) and advanced AIDS-Related Complex (ARC).
This information is designed to support, not replace, the relationship that exists between you and your doctor.